Emerging data from trials exploring mixing different types of vaccines demonstrate the practice is safe and could boost immunity.

Emerging data from trials exploring mixing different types of vaccines demonstrate the practice is safe and could boost immunity.
In a historic and surprise move, this week the US declared its support for a patent waiver on COVID-19 vaccines.
Assays using pseudoviruses have been indispensable in our efforts to halt the current pandemic.
Whilst vaccines against COVID-19 show there is light at the end of the tunnel, three main challenges still need to be addressed.
The two countries, in separate studies, begin human trials of potential vaccines against COVID-19.
A hydrogel delivery system boosts single-dose efficacy and provides a potential tool to fight future pandemics and vaccine inequity.
Scientists are investigating how fullerene nanomaterials can be used as antivirals against different variants of SARS-CoV-2 and other viruses.
Without independent vaccine manufacturing in Africa, the social and economic costs of the pandemic will only be prolonged.
The debate around COVID-19 boosters is highly nuanced, but a new computational model could help better inform policy around such measures in an evolving pandemic.
Molecular dynamics offer ways to improve lipid-based therapeutic delivery systems.